Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 543 Neoplasms 383 Carcinoma, Non-Small-Cell Lung 320 Colorectal Neoplasms 294 Lung Neoplasms 239 Prostatic Neoplasms 221 Carcinoma, Hepatocellular 213 Stomach Neoplasms 156 Pancreatic Neoplasms 153 Leukemia, Myeloid, Acute 140 Uterine Cervical Neoplasms 131 Multiple Myeloma 130 Recurrence 118 Rectal Neoplasms 113 Ovarian Neoplasms 108 Neoplasm Metastasis 104 Squamous Cell Carcinoma of Head and Neck 97 Head and Neck Neoplasms 88 Triple Negative Breast Neoplasms 86 Esophageal Neoplasms 85 Endometrial Neoplasms 81 Glioblastoma 80 Small Cell Lung Carcinoma 79 Colonic Neoplasms 79 Brain Neoplasms 76 Melanoma 72 Hematologic Neoplasms 66 Precursor Cell Lymphoblastic Leukemia-Lymphoma 65 Glioma 62 Disease 60

Interventions

Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Resectable Esophageal Cancer × Clear all

NCT07385664 2026-02-04

FAIR

Zhejiang Cancer Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡